Eye Drops and Lubricants Drugs Market Size- By Indication, By Type, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Introduction and Overview

According to SPER Market Research, 'Eye Drops and Lubricants Drugs Market Size- By Indication, By Type, By Distribution Channel, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Eye Drops and Lubricants Drugs Market is predicted to reach USD 33.47 million by 2033 with CAGR of 5.2%.

To treat eye disorders or restore normal eye function, ophthalmic eye drops are utilized to locally administer medication in the ocular cavities. Topical instillation of eye drops is the most popular and straightforward method of administering ocular drugs, and it is the preferred course of treatment. Globally, it is anticipated that the incidence and prevalence of eye infections will increase. The global market for ophthalmic eye drops is anticipated to grow as a result of the introduction of new pathogens, a rise in postoperative eye infections, and inadequate eye cleanliness.

Furthermore, COVID-19 has caused an unparalleled worldwide public health emergency that has affected almost all businesses. Its long-term effects are anticipated to have an impact on industry growth in the predicted period. The shift in the healthcare system to handle COVID-19 has resulted in postponed clinical trial results and cancelled drug launches. The eyes serve as a point of contact for direct aerosol inoculation entrance or escape.

Scope of the Report

Report Metric Details:

Market size available for years: 2019-2033

Base year considered: 2022

Forecast period: 2023-2033

Segments covered: By Indication, By Type, By Distribution Channel, By End-User

Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered: Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd. (Israel), Eye Point Pharmaceuticals, Inc, Bayer AG, Novartis AG, Nidek Co Ltd, Prestige Consumer Healthcare Inc. and others

Key Segments Covered:

By Indication: Based on the Indication, Global Eye Drops and Lubricants Drugs Market is segmented as; Conjunctivitis, Dry Eye, Glaucoma, Refractive Errors.

By Type: Based on the Type, Global Eye Drops and Lubricants Drugs Market is segmented as; Antibiotics, Hormones and Artificial Tears

By End-User: Based on the End-User, Global Eye Drops and Lubricants Drugs Market is segmented as; Hospitals, Homecare, Specialty Clinics and Others

Product Code: HLCA2379

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Eye Drops and Lubricants Drugs Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Eye Drops and Lubricants Drugs Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Eye Drops and Lubricants Drugs Market

7. Global Eye Drops and Lubricants Drugs Market, By Indication (USD Million)

7.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Indication, 2023-2033
7.2. Conjunctivitis
7.3. Dry Eye
7.4. Glaucoma
7.5. Refractive Errors
7.6. Others

8. Global Eye Drops and Lubricants Drugs Market, By Type (USD Million)

8.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Type, 2023-2033
8.2. Artificial Tears
8.3. Antibiotics
8.4. Hormones
8.5. Others

9. Global Eye Drops and Lubricants Drugs Market, By Distribution Channel (USD Million)

9.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By Distribution Channel, 2023-2033
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy

10. Global Eye Drops and Lubricants Drugs Market, By End-User (USD Million)

10.1. Global Eye Drops and Lubricants Market Value Share and Forecast, By End-User, 2023-2033
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
10.5. Others

11. Global Eye Drops and Lubricants Drugs Market Forecast, 2019-2033 (USD Million)

11.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share

12. Global Eye Drops and Lubricants Drugs Market, By Indication 2019-2033 (USD Million)

12.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Indication (2019-2026)
12.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Indication (2027-2033)

13. Global Eye Drops and Lubricants Drugs Market, By Type, 2019-2033 (USD Million)

13.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Type (2019-2026)
13.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Type (2027-2033)

14. Global Eye Drops and Lubricants Drugs Market, By Distribution Channel , 2019-2033 (USD Million)

14.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Distribution Channel (2019-2026)
14.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Distribution Channel (2027-2033)

15. Global Eye Drops and Lubricants Drugs Market, By End-User, 2019-2033 (USD Million)

15.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By End-User (2019-2026)
15.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By End-User (2027-2033)

16. Global Eye Drops and Lubricants Drugs Market, By Region, 2019-2033 (USD Million)

16.1. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Region (2019-2026)
16.2. Global Eye Drops and Lubricants Drugs Market Size and Market Share By Region (2027-2033)
16.3. Asia-Pacific
- 16.3.1. Australia
- 16.3.2. China
- 16.3.3. India
- 16.3.4. Japan
- 16.3.5. South Korea
- 16.3.6. Rest of Asia-Pacific
16.4. Europe
- 16.4.1. France
- 16.4.2. Germany
- 16.4.3. Italy
- 16.4.4. Spain
- 16.4.5. United Kingdom
- 16.4.6. Rest of Europe
16.5. Middle East and Africa
- 16.5.1. Kingdom of Saudi Arabia
- 16.5.2. United Arab Emirates
- 16.5.3. Rest of Middle East & Africa
16.6. North America
- 16.6.1. Canada
- 16.6.2. Mexico
- 16.6.3. United States
16.7. Latin America
- 16.7.1. Argentina
- 16.7.2. Brazil
- 16.7.3. Rest of Latin America

17. Company Profile

17.1. Bausch Health Companies Inc.
- 17.1.1. Company details
- 17.1.2. Financial outlook
- 17.1.3. Product summary
- 17.1.4. Recent developments
17.2. Bayer AG
- 17.2.1. Company details
- 17.2.2. Financial outlook
- 17.2.3. Product summary
- 17.2.4. Recent developments
17.3. EyePoint Pharmaceuticals,Inc
- 17.3.1. Company details
- 17.3.2. Financial outlook
- 17.3.3. Product summary
- 17.3.4. Recent developments
17.4. Fera Pharmaceuticals
- 17.4.1. Company details
- 17.4.2. Financial outlook
- 17.4.3. Product summary
- 17.4.4. Recent developments
17.5. Kubota Vision Inc
- 17.5.1. Company details
- 17.5.2. Financial outlook
- 17.5.3. Product summary
- 17.5.4. Recent developments
17.6. Novartis AG
- 17.6.1. Company details
- 17.6.2. Financial outlook
- 17.6.3. Product summary
- 17.6.4. Recent developments
17.7. Nidek Co Ltd
- 17.7.1. Company details
- 17.7.2. Financial outlook
- 17.7.3. Product summary
- 17.7.4. Recent developments
17.8. Prestige Consumer Healthcare Inc.
- 17.8.1. Company details
- 17.8.2. Financial outlook
- 17.8.3. Product summary
- 17.8.4. Recent developments
17.9. Teva Pharmaceutical Industries Ltd.
- 17.9.1. Company details
- 17.9.2. Financial outlook
- 17.9.3. Product summary
- 17.9.4. Recent developments
17.10. Others